Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Jul 22 01:09PM ET
7.47
Dollar change
-0.27
Percentage change
-3.49
%
Index- P/E- EPS (ttm)-6.20 Insider Own2.62% Shs Outstand47.83M Perf Week-18.00%
Market Cap362.67M Forward P/E- EPS next Y-3.56 Insider Trans-6.13% Shs Float47.28M Perf Month63.82%
Income-296.87M PEG- EPS next Q-1.25 Inst Own67.30% Short Float5.48% Perf Quarter59.96%
Sales19.00M P/S19.09 EPS this Y32.68% Inst Trans-4.79% Short Ratio0.93 Perf Half Y34.59%
Book/sh3.03 P/B2.47 EPS next Y18.28% ROA-42.38% Short Interest2.59M Perf Year-24.92%
Cash/sh11.45 P/C0.65 EPS next 5Y- ROE-106.11% 52W Range3.73 - 11.35 Perf YTD10.34%
Dividend Est.- P/FCF- EPS past 5Y-22.59% ROI-43.58% 52W High-34.19% Beta0.95
Dividend TTM- Quick Ratio9.27 Sales past 5Y302.35% Gross Margin-70.61% 52W Low100.27% ATR (14)0.88
Dividend Ex-Date- Current Ratio9.39 EPS Y/Y TTM-85.41% Oper. Margin-1332.12% RSI (14)57.37 Volatility11.02% 12.72%
Employees480 Debt/Eq3.70 Sales Y/Y TTM-82.73% Profit Margin-1562.22% Recom1.67 Target Price17.50
Option/ShortYes / Yes LT Debt/Eq3.64 EPS Q/Q16.70% Payout- Rel Volume0.49 Prev Close7.74
Sales Surprise35.12% EPS Surprise-6.32% Sales Q/Q59.34% EarningsMay 07 BMO Avg Volume2.80M Price7.47
SMA2020.73% SMA5036.60% SMA20028.40% Trades Volume802,043 Change-3.49%
Date Action Analyst Rating Change Price Target Change
Feb-29-24Downgrade Goldman Buy → Neutral $8
Dec-19-23Downgrade Mizuho Buy → Neutral $52 → $10
Mar-17-22Upgrade UBS Neutral → Buy $40
Jun-15-21Initiated BTIG Research Buy $46
May-21-21Initiated UBS Neutral $40
Apr-26-21Resumed Credit Suisse Outperform $78
Apr-01-21Upgrade Mizuho Neutral → Buy $52
Jan-07-21Upgrade Guggenheim Neutral → Buy $62
Nov-24-20Initiated H.C. Wainwright Buy $80
Nov-11-20Initiated Berenberg Buy
Jul-12-24 07:12AM
Jul-10-24 09:55AM
09:01AM
05:49AM
Jul-09-24 10:46AM
10:27AM Loading…
10:27AM
09:35AM
08:05AM
07:05AM
Jul-01-24 07:05AM
07:05AM
06:30AM
Jun-03-24 07:05AM
May-07-24 01:53PM
07:24AM
07:05AM Loading…
07:05AM
Mar-13-24 07:07AM
Feb-29-24 09:06AM
Feb-28-24 08:35AM
08:20AM
07:05AM
Feb-27-24 03:30AM
Dec-19-23 07:15AM
07:05AM
Dec-11-23 07:30PM
Dec-10-23 11:59AM
Dec-08-23 07:05AM
04:08AM
Nov-29-23 07:05AM
Nov-14-23 10:31PM
09:55AM Loading…
Nov-08-23 09:55AM
Nov-07-23 08:25AM
08:12AM
07:21AM
07:05AM
Oct-30-23 09:32AM
Oct-27-23 10:00AM
Oct-26-23 02:14PM
10:02AM
Oct-25-23 10:02AM
Oct-24-23 07:05AM
Oct-12-23 08:24AM
Oct-06-23 11:31AM
Oct-05-23 01:49PM
08:15AM
07:19AM
07:05AM
Oct-02-23 07:05AM
Sep-05-23 01:10PM
07:05AM
Sep-01-23 06:51PM
Aug-31-23 10:12PM
Aug-26-23 03:51PM
Aug-06-23 08:05AM
Aug-01-23 09:05AM
07:54AM
07:05AM
Jul-27-23 08:35PM
Jun-28-23 09:20AM
06:02AM
Jun-26-23 07:11AM
Jun-22-23 03:03PM
10:17AM
Jun-21-23 08:00PM
04:08PM
11:46AM
07:05AM
Jun-20-23 07:05AM
07:00AM
Jun-16-23 07:05AM
May-15-23 07:53AM
07:05AM
May-14-23 08:16AM
May-09-23 08:25AM
07:21AM
07:05AM
May-02-23 04:40PM
07:05AM
Apr-26-23 08:00PM
Apr-17-23 10:31AM
Mar-13-23 07:05AM
Mar-10-23 09:07AM
Mar-02-23 07:05AM
Feb-28-23 04:19PM
Feb-27-23 08:25AM
07:05AM
Feb-23-23 08:05AM
08:00AM
05:34AM
Feb-21-23 07:05AM
Jan-31-23 07:05AM
Jan-06-23 05:39AM
Dec-20-22 07:05AM
Dec-16-22 07:15AM
Dec-10-22 10:00AM
Nov-29-22 11:00AM
Nov-23-22 05:30PM
04:14PM
01:19PM
12:39PM
uniQure NV engages in the discovery, development, and commercialization of innovative gene therapies. Its discoveries intend to treat hemophilia, Huntington's disease, glybera, and cardiovascular problems. The company was founded by Sander J. van Deventer in 1998 and is headquartered in Amsterdam, the Netherlands.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Abi-Saab WalidChief Medical OfficerJun 26 '24Sale4.361,4476,309115,253Jun 28 04:21 PM
CALOZ PIERREChief Operating OfficerJun 17 '24Sale4.812,93614,122115,707Jun 20 08:53 AM
KLEMT CHRISTIANChief Financial OfficerJun 17 '24Sale4.801,6117,733164,837Jun 20 08:49 AM
Potts JeannetteChief Legal OfficerJun 13 '24Sale4.984,78123,80991,819Jun 17 07:46 PM
Gut RobertDirectorJun 13 '24Sale5.123,50417,94044,165Jun 17 07:19 PM
Kaye JackDirectorJun 13 '24Sale5.162,21811,4456,501Jun 17 07:14 PM
Balachandran MadhavanDirectorJun 13 '24Sale5.122,23111,42323,759Jun 17 07:30 PM
Springhorn Jeremy P.DirectorJun 13 '24Sale5.122,23111,42323,756Jun 17 07:40 PM
POST LEONARD EDirectorJun 13 '24Sale5.142,22211,42115,999Jun 18 06:11 PM
Jacques Rachelle SuzanneDirectorJun 13 '24Sale5.142,22111,41614,408Jun 17 06:42 PM
Meek David D.DirectorJun 13 '24Sale5.122,22911,41220,252Jun 17 07:35 PM
Soteropoulos PaulaDirectorJun 13 '24Sale5.142,22011,41120,203Jun 17 07:24 PM
Kapusta Matthew CCEO, Managing DirectorFeb 26 '24Sale6.3527,904177,190440,839Feb 28 04:17 PM
KLEMT CHRISTIANChief Financial OfficerFeb 26 '24Sale6.3815,906101,480116,948Feb 28 04:21 PM
CALOZ PIERREChief Operating OfficerFeb 26 '24Sale6.479,45561,17485,643Feb 28 04:33 PM
Dolmetsch RicardoPresident, R&DSep 18 '23Sale7.465,84143,574163,404Sep 20 04:45 PM